CRH and Ventriculomegaly: Results from the ELGAN (Extremely Low Gestational Age Newborns) study suggest that extremes of pCRH expression identify risk for adverse fetal developmental outcomes: low CRH mRNA concentrations are associated with placenta inflammation and predict ventriculomegaly whereas high CRH mRNA concentrations predict motor dysfunctions (33).